- to
farampator was transferred. The
development of
farampator was
eventually terminated,
reportedly due to
concerns about cardiac toxicity.
Farampator has...
- drug
development program are CX-516 (Ampalex), CX-546, CX-614, CX-691 (
farampator), and CX-717. ORG-26576 was
developed by
RespireRx but then
licensed to...
-
allosteric modulators:
Aniracetam Cyclothiazide CX-516 CX-546 CX-614
Farampator (CX-691, ORG-24448) CX-717 CX-1739 CX-1942
Diazoxide Hydrochlorothiazide...
-
allosteric modulators:
Aniracetam Cyclothiazide CX-516 CX-546 CX-614
Farampator (CX-691, ORG-24448) CX-717 CX-1739 CX-1942
Diazoxide Hydrochlorothiazide...
-
allosteric modulators:
Aniracetam Cyclothiazide CX-516 CX-546 CX-614
Farampator (CX-691, ORG-24448) CX-717 CX-1739 CX-1942
Diazoxide Hydrochlorothiazide...
-
allosteric modulators:
Aniracetam Cyclothiazide CX-516 CX-546 CX-614
Farampator (CX-691, ORG-24448) CX-717 CX-1739 CX-1942
Diazoxide Hydrochlorothiazide...
-
allosteric modulators:
Aniracetam Cyclothiazide CX-516 CX-546 CX-614
Farampator (CX-691, ORG-24448) CX-717 CX-1739 CX-1942
Diazoxide Hydrochlorothiazide...
-
fanetizole (INN)
Fansidar fantofarone (INN)
fantridone (INN)
faralimomab (INN)
farampator (USAN)
Fareston Fareston (Orion Corp.)
farletuzumab (USAN, INN) faropenem...
-
allosteric modulators:
Aniracetam Cyclothiazide CX-516 CX-546 CX-614
Farampator (CX-691, ORG-24448) CX-717 CX-1739 CX-1942
Diazoxide Hydrochlorothiazide...
-
allosteric modulators:
Aniracetam Cyclothiazide CX-516 CX-546 CX-614
Farampator (CX-691, ORG-24448) CX-717 CX-1739 CX-1942
Diazoxide Hydrochlorothiazide...
